NCT00004582View on ClinicalTrials.gov

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/Ritonavir

DRUG

Efavirenz

Trial Locations (1)

94103

ViRx Inc, San Francisco

All Listed Sponsors
lead

ViRx

INDUSTRY